Illinois Research and Scholarship

 

This collection contains all UIUC research and scholarship which doesn't currently fall under the jurisdiction of a specific community or collection in IDEALS.

All UIUC faculty, staff, and graduate students are encouraged to immediately submit their research to this collection. The submitted work will be reviewed by a small group in the University Library to ensure that it falls within the scope of the IDEALS Collection Policy. In the future, their department or research center may choose to link to their research into a departmental-specific collection.

At this time, undergraduate students at UIUC must ask a faculty or staff member to submit their undergraduate research to this collection. In the future, we hope to also allow undergraduates to immediately submit their own research.

If you have any problems or questions with this collection, or are affliated with UIUC and unable to submit to this collection, please contact ideals@library.illinois.edu.

Recent AdditionsRSS feed

  • Sherkow, Jacob S.; Scott, Christopher Thomas (Cell Stem Cell, 2015-05-07)
    Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to stem cell patents, ...

    application/pdf

    application/pdfPDF (275kB)
  • Sherkow, Jacob S.; Greely, Henry T. (Annual Review of Genetics, 2015-12-04)
    The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, Inc. declared, for the first time, that isolated human genes cannot be patented. Many have wondered how genes were ever the ...

    application/pdf

    application/pdfPDF (336kB)
  • Rai, Arti K.; Sherkow, Jacob S. (Nature Biotechnology, 2016-03-10)
    What have we learned from 20 tumultuous years of patent law in the life sciences? Is patenting likely to be as important for the industry in the future?

    application/pdf

    application/pdfPDF (729kB)
  • Sherkow, Jacob S. (Nature, 2016-04-16)
    The CRISPR–Cas9 patent battle demonstrates how overzealous efforts to commercialize technology can damage science.

    application/pdf

    application/pdfPDF (839kB)
  • Sherkow, Jacob S. (Nature Biotechnology, 2016-05-06)
    Patents have long been the most important legal assets of biotech companies. Increasingly, however, biotech firms find themselves on one side of a divide: as either traditional product companies or platform companies. Given ...

    application/pdf

    application/pdfPDF (273kB)

Collection Statistics